Abstract
The minimal inhibitory concentration and the 50% mouse protective dose for five key penicillins are presented. Such data provide a useful guide in evaluating the activity of new penicillins, in comparison with those already commercially available, and establishes the amounts of antibiotic necessary to obtain a PD50 for several experimental model infections in mice.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Naumann P. Laboratory and clinical evaluation of dicloxacillin. Antimicrob Agents Chemother (Bethesda) 1965;5:937–946. [PubMed] [Google Scholar]